← All companies
YARW
Yarrow Bioscience Inc
$33.59
-1.43 -4.08%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.12B
Revenue (TTM)
$570K
Net income (TTM)
-$26.5M
EPS (TTM)
$-0.62
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$24.6M
Total assets
$25.9M
Gross margin
—
52-week range
$14.05 – $46.95
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jul 30, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Regulation FD disclosure
Jul 28, 2026
8-K
Regulation FD disclosure; Other events
Jul 21, 2026
8-K
Shareholder vote results
Jul 20, 2026
8-K
Regulation FD disclosure
Jul 14, 2026
8-K
Regulation FD disclosure; Other events
Jul 10, 2026
8-K
Regulation FD disclosure
May 21, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
8-K
Delisting notice or listing-rule failure
Mar 11, 2026
10-K
Fiscal year ended 2025-12-31
Feb 27, 2026
8-K
Entered a material agreement
Jan 30, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure
Dec 17, 2025
8-K
Shareholder vote results
Dec 12, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Delisting notice or listing-rule failure
Sep 12, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release); Director or officer change
Aug 14, 2025
8-K
Results of operations (earnings release); Other events
Jul 30, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
10-K
Fiscal year ended 2024-12-31
Mar 6, 2025
8-K
Results of operations (earnings release)
Mar 6, 2025
8-K
Other events
Jan 13, 2025
8-K
Other events
Dec 23, 2024
8-K
Director or officer change; Shareholder vote results
Dec 12, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Other events
Sep 12, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Results of operations (earnings release)
Aug 14, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release)
May 9, 2024
10-K
Fiscal year ended 2023-12-31
Mar 1, 2024
8-K
Results of operations (earnings release)
Feb 29, 2024
8-K
Director or officer change; Regulation FD disclosure
Jan 3, 2024
8-K
Director or officer change; Shareholder vote results
Dec 13, 2023
10-Q
Quarter ended 2023-09-30
Nov 13, 2023
8-K
Results of operations (earnings release)
Nov 13, 2023
8-K
Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Unregistered sale of equity; Item 5.08; Regulation FD disclosure; Other events
Oct 30, 2023